ACLARIS THERAPEUTICS INC

ACLARIS THERAPEUTICS INC logo
🇮🇳India
Ownership
Public
Established
2009-01-01
Employees
101
Market Cap
$84.9M
Website
http://www.aclaristx.com

Dose-Response Profile of A-101 in Subjects With Seborrheic Keratosis

First Posted Date
2014-06-11
Last Posted Date
2019-01-03
Lead Sponsor
Aclaris Therapeutics, Inc.
Target Recruit Count
172
Registration Number
NCT02160626
Locations
🇺🇸

The Education & Research Foundation, Inc., Lynchburg, Virginia, United States

🇺🇸

Oregon Medical Research Center, Portland, Oregon, United States

🇺🇸

Gwinnett Clinical Research Center, Inc., Snellville, Georgia, United States

and more 2 locations

Study of Safety, Tolerability and Effectiveness of A-101 in Subjects With Seborrheic Keratosis

First Posted Date
2013-11-19
Last Posted Date
2018-12-11
Lead Sponsor
Aclaris Therapeutics, Inc.
Target Recruit Count
35
Registration Number
NCT01986920
Locations
🇺🇸

DermResearch, Inc., Austin, Texas, United States

© Copyright 2024. All Rights Reserved by MedPath